Back to Search
Start Over
ERS Genomics & AlgenScribe enter into CRISPR/Cas9 licensing agreement
- Source :
- PharmaBiz. September 6, 2023
- Publication Year :
- 2023
-
Abstract
- ERS Genomics Limited (ERS), a biotechnology company, has announce a new license agreement with AlgenScribe SAS (AlgenScribe). This is a non-exclusive licensing agreement granting AlgenScribe access to the ERS CRISPR/Cas9 [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.763521859